Aaron Pontsler

Title: Innovations of Aaron Pontsler

Introduction

Aaron Pontsler is an accomplished inventor based in West Jordan, UT (US). He has made significant contributions to the field of biotechnology, particularly in the area of human metabotropic glutamate receptors. With a total of 4 patents to his name, Pontsler's work has implications for understanding and manipulating receptor functions.

Latest Patents

Pontsler's latest patents focus on human metabotropic glutamate receptors, specifically nucleic acids encoding these receptors and their various subtypes. The invention provides nucleic acids that encode mGluR1, mGluR2, mGluR3, and mGluR5 subtypes. These nucleic acids are not only useful for producing metabotropic glutamate receptor subtypes but also serve as probes for identifying and isolating related human receptor subunits. Furthermore, the invention includes methods for using these receptor subtypes to identify and characterize compounds that affect receptor function, such as agonists, antagonists, and modulators.

Career Highlights

Throughout his career, Pontsler has worked with notable organizations, including Merck & Co., Inc. and The Salk Institute Biotechnology Industrial Associates, Inc. His experience in these prestigious institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Pontsler's coworkers include Lorrie P. Daggett and Steven B. Ellis. Their collaborative efforts have further advanced the understanding of metabotropic glutamate receptors and their applications.

Conclusion

Aaron Pontsler's innovative work in the field of biotechnology, particularly regarding human metabotropic glutamate receptors, showcases his expertise and dedication to advancing scientific knowledge. His contributions have the potential to impact various therapeutic areas significantly.